Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
300 participants
INTERVENTIONAL
2025-04-21
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing Brain Injury Using Portable Magnetic Resonance Imaging (MRI)
NCT05469139
Hyperfine Portable MRI in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging
NCT04436068
Identification of Brain Injury Using Portable MRI
NCT07197918
Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems
NCT07296263
Traumatic Brain Injury Biological Diagnosis Via High Definition Tractography Asymmetry Screening
NCT02728960
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants in the SOC arm will not receive a portable MRI scan as part of their initial evaluation. Regardless of randomization arm, all participants will receive their scheduled conventional MRI as usual. Information on each participant's clinical course, conventional imaging, and length of stay will be collected, regardless of treatment group. On a rolling basis, surveys containing deidentified clinical information and portable MRI scans will be administered to a physician panel to assess the impact of portable MRI scans on decision making and provider satisfaction.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Portable Brain MRI scan
Participants in the scan arm will receive a portable MRI scan as soon as the scanner is available after randomization as part of their initial evaluation. Regardless of randomization arm, all participants will receive their scheduled conventional MRI as usual.
Swoop Plus Mk2.0
portable brain MRI scanner
Standard of Care
Participants in the SOC arm will not receive a portable MRI scan as part of their initial evaluation. Regardless of randomization arm, all participants will receive their scheduled conventional MRI as usual.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Swoop Plus Mk2.0
portable brain MRI scanner
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Order to receive conventional brain MRI imaging originating in the YNHH Adult ED
Exclusion Criteria
* Contraindications to 1.5T MRI evaluation, including:
1. Cardiac Pacemaker or defibrillator
2. Aneurysm clip
3. Implants or devices attached to the body in the chest or above, such as:
1. Nerve stimulator
2. Deep brain stimulator
3. Programmable shunt
4. Stent
5. Pain pump
6. Artificial extremity
4. Implants in the ears (hearing aid or cochlear implant
5. Any shrapnel, pellets, bullets, metallic fragments, or other metallic foreign body above the chest
6. Metallic joints, rods, screws, or other orthopedic implants in or above the chest
7. Braces, dentures, removable teeth, or dental expanders that cannot be removed.
8. Body piercings in or above the chest that cannot be removed.
9. MRI-incompatible Tracheostomy tube or Swan Ganz catheter in place
10. Status Epilepticus or anyone previously seizing deemed by the physician not to be suitable for pMRI
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hyperfine
INDUSTRY
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adam de Havenon, MD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale New Haven Health Emergency Department
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2000039013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.